Gerlach MM, Stelling-Germani A, Wu CT, Newrzela S, Döring C, Vela V, Müller A, Hartmann S, Tzankov A. SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy. Haematologica [Internet]. 2021Feb.1 [cited 2026Nov.8];106(2):619-21. Available from: https://haematologica.org/article/view/9721